Product Innovation in Consumer Health

Delivery

This report comes in PPT.

Key findings

GLP-1 support/boosting products rush to fill a consumer void, as weight loss has reached fever pitch

Entering 2025, the global consumer health marketplace is convulsed by the surging consumer interest in weight loss, driven by the proliferation of prescription-based GLP-1 injectable solutions. Consumer health players have responded quickly by offering products that treat GLP-1 users’ side effects while on the drug (or after cycling off), or by promoting substitutes that claim to mimic the effects of the injectables for consumers who would prefer another option. This marketplace is still in flux, with market leaders likely to emerge in 2025.

Consumer interest in novel and on-the-go formats is stimulating the development of fast-acting and fun vitamin and supplement solutions

The second wave of on-the-go formats in vitamins and dietary supplements and sports nutrition is upon us and is only set to deepen in 2025. Extending from popular format innovations in the 2010s, like gummies and RTD beverages, this new wave of format-based innovation is centred on ease of use and ease of transport, while new products in this space are projecting a sense of fun and emphasising the products’ fast-acting and high absorption qualities.

Innovation in longevity and cellular health functionality is meeting demand from consumers worrying about longer term healthy ageing outcomes

A new cluster of products marketed against cellular ageing is reacting to perennial consumer demands for products that can assist with the effects of longer-term ageing. Though very much a niche entering 2025, and with a risk of overpromising, these products have seen fast-rising interest in markets across North America, Western Europe and Asia Pacific, reflecting the broad-based nature of age-related health concerns in a rapidly ageing world, where consumers are aiming to maximise healthy life years without limitations.